L3VLUP
ProSign in

RCKT · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

RCKTLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • RCKT
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterRCKTLLY
Q3 2020none listed holders, n.a.33 holders, $14.1bn
Q4 20203 holders, $228m29 holders, $17.3bn
Q1 20212 holders, $178m24 holders, $23.0bn
Q2 20213 holders, $210m24 holders, $27.8bn
Q3 20211 holders, $50m31 holders, $29.9bn
Q4 20211 holders, $41m31 holders, $34.7bn
Q1 20223 holders, $37m24 holders, $35.3bn
Q2 20222 holders, $36m33 holders, $42.7bn
Q3 20222 holders, $42m31 holders, $43.4bn
Q4 20222 holders, $71m31 holders, $46.6bn
Q1 20233 holders, $86m33 holders, $44.3bn
Q2 20231 holders, $87m37 holders, $59.6bn
Q3 20232 holders, $280m44 holders, $67.6bn
Q4 20233 holders, $395m45 holders, $73.6bn
Q1 20243 holders, $422m41 holders, $95.3bn
Q2 20244 holders, $357m43 holders, $110bn
Q3 20244 holders, $330m45 holders, $107bn
Q4 20245 holders, $320m46 holders, $93.9bn
Q1 20251 holders, $35m42 holders, $98.4bn
Q2 20252 holders, $21m43 holders, $93.2bn
Q3 20252 holders, $28m39 holders, $86.7bn
Q4 20252 holders, $9.6m41 holders, $123bn
Q1 20262 holders, $13m39 holders, $106bn
Q2 20262 holders, $14m44 holders, $132bn
RCKT

Rocket Pharmaceuticals Inc

Holders
2
Reported value
$13m
Buyers
15
Sellers
14

Breadth +1 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
LLY

Eli Lilly & Co

Holders
39
Reported value
$106bn
Buyers
25
Sellers
25

Breadth 0 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2026

Among the 41 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only RCKT (2)

Maverick Capital Ltd, PDT Partners LLC

Only LLY (39)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, ARK Investment Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Millennium Management LLC, and 14 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →